1228690-36-5,MFCD22665734
Catalog No.:AA000JKU

1228690-36-5 | Am095

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$15.00   $11.00
- +
5mg
98%
in stock  
$37.00   $26.00
- +
10mg
98%
in stock  
$54.00   $38.00
- +
25mg
98%
in stock  
$90.00   $63.00
- +
50mg
98%
in stock  
$151.00   $106.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA000JKU
Chemical Name:
Am095
CAS Number:
1228690-36-5
Molecular Formula:
C27H24N2O5
Molecular Weight:
456.4899
MDL Number:
MFCD22665734
SMILES:
OC(=O)Cc1ccc(cc1)c1ccc(cc1)c1onc(c1NC(=O)O[C@@H](c1ccccc1)C)C
Properties
Computed Properties
 
Complexity:
666  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
34  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
8  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
5  

Downstream Synthesis Route

[1]Patent:US2010/152257,2010,A1.Locationinpatent:Page/Pagecolumn25

[2]Patent:WO2011/159550,2011,A2.Locationinpatent:Page/Pagecolumn80

[1]Patent:WO2011/159550,2011,A2

[1]Patent:WO2011/159550,2011,A2

[1]Patent:WO2011/159550,2011,A2

[1]Patent:WO2011/159550,2011,A2

Literature

Title: Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts.

Journal: Journal of medicinal chemistry 20120913

Title: Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist.

Journal: The Journal of pharmacology and experimental therapeutics 20110301

Title: Castelino FV, et al. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Arthritis Rheum. 2011 May;63(5):1405-15.

Title: Ruisanchez E, et al. Lysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase. FASEB J. 2014 Feb;28(2):880-90.

Title: Swaney, J. S., et al. Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist. Journal of Pharmacology and Experimental Therapeutics (2011), 336(3), 693-700.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1228690-36-5 Molecular Formula|1228690-36-5 MDL|1228690-36-5 SMILES|1228690-36-5 Am095
Catalog No.: AA000JKU
1228690-36-5,MFCD22665734
1228690-36-5 | Am095
Pack Size: 1mg
Purity: 98%
in stock
$15.00 $11.00
Pack Size: 5mg
Purity: 98%
in stock
$37.00 $26.00
Pack Size: 10mg
Purity: 98%
in stock
$54.00 $38.00
Pack Size: 25mg
Purity: 98%
in stock
$90.00 $63.00
Pack Size: 50mg
Purity: 98%
in stock
$151.00 $106.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA000JKU
Chemical Name: Am095
CAS Number: 1228690-36-5
Molecular Formula: C27H24N2O5
Molecular Weight: 456.4899
MDL Number: MFCD22665734
SMILES: OC(=O)Cc1ccc(cc1)c1ccc(cc1)c1onc(c1NC(=O)O[C@@H](c1ccccc1)C)C
Properties
Complexity: 666  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 34  
Hydrogen Bond Acceptor Count: 6  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 8  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 5  
Downstream Synthesis Route
1228690-38-7    1228690-36-5 

[1]Patent:US2010/152257,2010,A1.Locationinpatent:Page/Pagecolumn25

[2]Patent:WO2011/159550,2011,A2.Locationinpatent:Page/Pagecolumn80

98-86-2    1228690-36-5 

[1]Patent:WO2011/159550,2011,A2

14062-25-0    1228690-36-5 

[1]Patent:WO2011/159550,2011,A2

1517-69-7    1228690-36-5 

[1]Patent:WO2011/159550,2011,A2

859169-20-3    1228690-36-5 

[1]Patent:WO2011/159550,2011,A2

Literature fold

Title: Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts.

Journal: Journal of medicinal chemistry20120913

Title: Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist.

Journal: The Journal of pharmacology and experimental therapeutics20110301

Title: Castelino FV, et al. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Arthritis Rheum. 2011 May;63(5):1405-15.

Title: Ruisanchez E, et al. Lysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase. FASEB J. 2014 Feb;28(2):880-90.

Title: Swaney, J. S., et al. Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist. Journal of Pharmacology and Experimental Therapeutics (2011), 336(3), 693-700.

Building Blocks More >
123-48-8
123-48-8
3-Heptene, 2,2,4,6,6-pentamethyl-
AA000JUC | MFCD00884605
123280-64-8
123280-64-8
3,6-Dichloropicoline
AA000K6L | MFCD00778766
1234319-14-2
1234319-14-2
2-(4-(Difluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
AA000KHL | MFCD16996278
1235560-28-7
1235560-28-7
ABT-639
AA000KPR | MFCD29924737
123910-88-3
123910-88-3
Methyl 4-(4-hydroxybutyl)benzoate
AA000L53 | MFCD12547324
1240518-90-4
1240518-90-4
4-Methylmorpholine-3-carboxylic acid hydrochloride
AA000LDW | MFCD06738943
124276-83-1
124276-83-1
1-(3-Bromophenyl)cyclopropanecarbonitrile
AA000LPJ | MFCD07374414
1245506-61-9
1245506-61-9
2-Chloro-5-methoxy-4-methylpyrimidine
AA000M45 | MFCD22394135
124618-80-0
124618-80-0
3-Pentyn-1-amine, hydrochloride (1:1)
AA000MEH | MFCD24369241
124830-45-1
124830-45-1
Cyclohexanecarboxylic acid, 4-amino-, 1,1-dimethylethyl ester
AA000MPQ | MFCD12766687
Submit
© 2017 AA BLOCKS, INC. All rights reserved.